NASDAQ:ICLR - Icon Stock Price, Forecast & News

Icon trades on the NASDAQ under the ticker symbol "ICLR."

Icon Plc (NASDAQ:ICLR) announced its quarterly earnings data on Wednesday, October, 23rd. The medical research company reported $1.74 EPS for the quarter, hitting the Zacks' consensus estimate of $1.74. The medical research company had revenue of $710.40 million for the quarter, compared to analyst estimates of $709.75 million. Icon had a net margin of 13.16% and a return on equity of 24.86%. The firm's revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.54 earnings per share. View Icon's Earnings History.

Icon is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Icon.

Icon updated its FY20 earnings guidance on Tuesday, January, 14th. The company provided earnings per share (EPS) guidance of $7.55-7.85 for the period, compared to the Thomson Reuters consensus estimate of $7.71. The company issued revenue guidance of $2.97-3.09 billion, compared to the consensus revenue estimate of $3.03 billion.

9 brokers have issued 1-year target prices for Icon's shares. Their forecasts range from $154.00 to $185.00. On average, they expect Icon's share price to reach $166.88 in the next twelve months. This suggests that the stock has a possible downside of 5.1%. View Analyst Price Targets for Icon.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Icon in the last year. There are currently 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Icon.

News stories about ICLR stock have trended positive on Tuesday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Icon earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave news coverage about the medical research company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the immediate future. View News Stories for Icon.

Icon saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,180,000 shares, an increase of 16.8% from the December 15th total of 1,010,000 shares. Based on an average trading volume of 261,500 shares, the days-to-cover ratio is currently 4.5 days. Currently, 2.2% of the shares of the stock are short sold. View Icon's Current Options Chain.

Some companies that are related to Icon include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), Charles River Laboratories Intl. (CRL), PRA Health Sciences (PRAH), Syneos Health (SYNH), Exelixis (EXEL), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Intrexon (XON), Sorrento Therapeutics (SRNE), Auxly Cannabis Group (CBWTF), STARPHARMA HOLD/S (SPHRY) and Luna Innovations (LUNA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Icon investors own include Pfizer (PFE), Gilead Sciences (GILD), CVS Health (CVS), Mastercard (MA), Procter & Gamble (PG), Post (POST), Visa (V), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and Amgen (AMGN).

Icon's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Peregrine Capital Management LLC (0.42%), Summit Creek Advisors LLC (0.27%), LVM Capital Management Ltd. MI (0.12%), Henry James International Management Inc. (0.06%), Tealwood Asset Management Inc. (0.04%) and Welch & Forbes LLC (0.04%).

ICLR stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, RBA Wealth Management LLC, Arden Trust Co, Summit Creek Advisors LLC, Welch & Forbes LLC, Tealwood Asset Management Inc., Raymond James Trust N.A. and Somerset Trust Co.

ICLR stock was acquired by a variety of institutional investors in the last quarter, including Diversified Trust Co, First National Bank of Omaha, Henry James International Management Inc., We Are One Seven LLC, LVM Capital Management Ltd. MI, Allred Capital Management LLC, Bangor Savings Bank and Lenox Wealth Advisors LLC.

Shares of ICLR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ICLR stock can currently be purchased for approximately $175.78.

Icon has a market capitalization of $9.49 billion and generates $2.60 billion in revenue each year. The medical research company earns $322.66 million in net income (profit) each year or $6.29 on an earnings per share basis. Icon employs 13,670 workers across the globe.View Additional Information About Icon.

The official website for Icon is http://www.iconplc.com/.

Icon's mailing address is SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN, DUBLIN L2, 00000. The medical research company can be reached via phone at 353-1291-2000.